{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T18:39:41Z","timestamp":1709577581249},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00347-005-1183-9","type":"journal-article","created":{"date-parts":[[2005,3,3]],"date-time":"2005-03-03T02:14:10Z","timestamp":1109816050000},"page":"485-490","source":"Crossref","is-referenced-by-count":8,"title":["Zystoides Makula\u00f6dem bei Uveitis"],"prefix":"10.1007","volume":"102","author":[{"given":"S. R.","family":"Thurau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00006982-200410001-00002","volume":"24","author":"Aiello","year":"2004","unstructured":"Aiello LP, Brucker AJ, Chang S et al. (2004) Evolving guidelines for intravitreous injections. Retina 24:3\u201319","journal-title":"Retina"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","volume":"108","author":"Antcliff","year":"2001","unstructured":"Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108:765\u2013772","journal-title":"Ophthalmology"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0161-6420(99)00087-1","volume":"107","author":"Antcliff","year":"2000","unstructured":"Antcliff RJ, Stanford MR, Chauhan DS et al. (2000) Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology 107:593\u2013599","journal-title":"Ophthalmology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.0022-3042.2001.00740.x","volume":"80","author":"Antonetti","year":"2002","unstructured":"Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC (2002) Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 80:667\u2013677","journal-title":"J Neurochem"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1167\/iovs.03-0351","volume":"45","author":"Bailey","year":"2004","unstructured":"Bailey TA, Kanuga N, Romero IA, Greenwood J, Luthert PJ, Cheetham ME (2004) Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 45:675\u2013684","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR6","doi-asserted-by":"crossref","unstructured":"Becker MD, Heiligenhaus A, de Smet M, Davis JL (2005) Vitrectomy in uveitis. In: Pleyer U, Mondino B (eds) Uveitis and immunological disorders. Springer, Berlin Heidelberg New York Tokio, pp 273\u2013284","DOI":"10.1007\/3-540-26752-2_17"},{"key":"CR7","first-page":"1377","volume":"26","author":"Bunt Milam","year":"1985","unstructured":"Bunt Milam AH, Saari JC, Klock IB, Garwin GG (1985) Zonulae adherentes pore size in the external limiting membrane of the rabbit retina. Invest Ophthalmol Vis Sci 26:1377\u20131380","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.exer.2004.04.008","volume":"79","author":"Castro","year":"2004","unstructured":"Castro MR, Lutz D, Edelman JL (2004) Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization. Exp Eye Res 79:275\u2013285","journal-title":"Exp Eye Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","volume":"88","author":"Durrani","year":"2004","unstructured":"Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI (2004) Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol 88:1159\u20131162","journal-title":"Br J Ophthalmol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/eye.2001.5","volume":"15","author":"Freeman","year":"2001","unstructured":"Freeman G (2001) Cystoid macular oedema in uveitis: an unsolved problem. Eye 15:12\u201317","journal-title":"Eye"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1002196930726","volume":"97","author":"Gillies","year":"1999","unstructured":"Gillies MC (1999) Regulators of vascular permeability: potential sites for intervention in the treatment of macular edema. Doc Ophthalmol 97:251\u2013260","journal-title":"Doc Ophthalmol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1002130005227","volume":"97","author":"Guex","year":"1999","unstructured":"Guex Crosier Y (1999) The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol 97:297\u2013309","journal-title":"Doc Ophthalmol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00347-003-0975-z","volume":"101","author":"Jaissle","year":"2004","unstructured":"Jaissle GB, Szurman P, Bartz Schmidt KU (2004) Nebenwirkungen und Komplikationen der intravitrealen Triamcinolonacetonid-Therapie. Ophthalmologe 101:121\u2013128","journal-title":"Ophthalmologe"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00347-003-0982-0","volume":"101","author":"Jonas","year":"2004","unstructured":"Jonas JB, Kreissig I, Kamppeter B, Degenring RF (2004) Intravitreales Triamcinolonacetonid zur Behandlung intraokularer \u00f6dematoser und neovaskul\u00e4rer Erkrankungen. Ophthalmologe 101:113\u2013120","journal-title":"Ophthalmologe"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajo.2004.02.053","volume":"138","author":"Karacorlu","year":"2004","unstructured":"Karacorlu M, Mudun B, Ozdemir H, Karacorlu SA, Burumcek E (2004) Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behcet disease. Am J Ophthalmol 138:289\u2013291","journal-title":"Am J Ophthalmol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/sj.eye.6700464","volume":"17","author":"Lashay","year":"2003","unstructured":"Lashay AR, Rahimi A, Chams H et al. (2003) Evaluation of the effect of acetazolamide on cystoid macular oedema in patients with Behcet\u2019s disease. Eye 17:762\u2013766","journal-title":"Eye"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ophtha.2003.08.037","volume":"111","author":"Markomichelakis","year":"2004","unstructured":"Markomichelakis NN, Halkiadakis I, Pantelia E, Peponis V, Patelis A, Theodossiadis P, Theodossiadis G (2004) Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. Ophthalmology 111:946\u2013953","journal-title":"Ophthalmology"},{"key":"CR18","first-page":"1380","volume":"119","author":"Martidis","year":"2001","unstructured":"Martidis A, Duker JS, Puliafito CA (2001) Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 119:1380\u20131383","journal-title":"Arch Ophthalmol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S0039-6257(02)00294-1","volume":"47","author":"Miyake","year":"2002","unstructured":"Miyake K, Ibaraki N (2002) Prostaglandins and cystoid macular edema. Surv Ophthalmol 47 [Suppl 1]:S203\u2013218","journal-title":"Surv Ophthalmol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1023\/A:1002525619764","volume":"97","author":"Rojas","year":"1999","unstructured":"Rojas B, Zafirakis P, Christen W, Markomichelakis NN, Foster CS (1999) Medical treatment of macular edema in patients with uveitis. Doc Ophthalmol 97:399\u2013407","journal-title":"Doc Ophthalmol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1076\/ocii.10.4.239.15589","volume":"10","author":"Rothova","year":"2002","unstructured":"Rothova A (2002) Medical treatment of cystoid macular edema. Ocul Immunol Inflamm 10:239\u2013246","journal-title":"Ocul Immunol Inflamm"},{"key":"CR22","doi-asserted-by":"crossref","unstructured":"Rothova A, Suttorp van Schulten MS, Frits Treffers W, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80:332\u2013336; Issn: 0007\u20131161","DOI":"10.1136\/bjo.80.4.332"},{"key":"CR23","doi-asserted-by":"crossref","unstructured":"Tamesis RR, Rodriguez A, Christen WG, Akova YA, Messmer E, Foster CS (1996) Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. Ophthalmology 103:768\u2013775; Issn: 0161\u20136420","DOI":"10.1016\/S0161-6420(96)30618-0"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0161-6420(97)30065-7","volume":"104","author":"Thach","year":"1997","unstructured":"Thach AB, Dugel PU, Flindall RJ, Sipperley JO, Sneed SR (1997) A comparison of retrobulbar versus sub-Tenon\u2019s corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology 104:2003\u20132008","journal-title":"Ophthalmology"},{"key":"CR25","doi-asserted-by":"crossref","unstructured":"Thurau SR, Wildner G (2005) Immunomodulatory therapy in uveitis. In: Pleyer U, Mondino B (eds) Uveitis and immunological disorders. Springer, Berlin Heidelberg New York Tokio, pp 255\u2013271","DOI":"10.1007\/3-540-26752-2_16"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/bjo.2003.033894","volume":"88","author":"Tretiach","year":"2004","unstructured":"Tretiach M, Madigan MC, Gillies MC (2004) Conditioned medium from mixed retinal pigmented epithelium and Muller cell cultures reduces in vitro permeability of retinal vascular endothelial cells. Br J Ophthalmol 88:957\u2013961","journal-title":"Br J Ophthalmol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00347-002-0691-0","volume":"100","author":"Wiechens","year":"2003","unstructured":"Wiechens B, Reichelt JA, Urbat C, Nolle B (2003) Pars-plana-Vitrektomie bei zystoidem Makula\u00f6dem bei verschiedenen Formen der chronischen Uveitis. Ophthalmologe 100:33\u201343","journal-title":"Ophthalmologe"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1002143802926","volume":"97","author":"Wolfensberger","year":"1999","unstructured":"Wolfensberger TJ (1999) The role of carbonic anhydrase inhibitors in the management of macular edema. Doc Ophthalmol 97:387\u2013397","journal-title":"Doc Ophthalmol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","volume":"29","author":"Young","year":"2001","unstructured":"Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 29:2\u20136","journal-title":"Clin Experiment Ophthalmol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1002469503835","volume":"97","author":"Zierhut","year":"1999","unstructured":"Zierhut M, Thiel HJ, Schlote T (1999) Treatment of uveitic macular edema with acetazolamide. Doc Ophthalmol 97:409\u2013413","journal-title":"Doc Ophthalmol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-005-1183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-005-1183-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-005-1183-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:46:34Z","timestamp":1559036794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-005-1183-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1007\/s00347-005-1183-9","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}